UPDATE: JPMorgan Downgrades Actus Medical (AFIB) to Neutral
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
Acutus Medical Reports Fourth Quarter and Full Year 2020 Financial Results
March 18, 2021 6:00 AM EDTCARLSBAD, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (Acutus) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the fourth quarter and full year ended December 31, 2020.
Recent Highlights:
Reported revenue of $2.6 million in the fourth quarter of 2020, compared to $0.7 million in the same quarter last year.Reported revenue of $8.5 million for the full year of 2020, compared to $2.8 million for the full year of... MoreAcutus Medical Board Appoints John Sheridan as a New Director
March 18, 2021 6:00 AM EDTCARLSBAD, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB) today announced the appointment of John Sheridan to the Company's Board of Directors effective March 17, 2021.
Since March 2019, Mr. Sheridan has been the President and Chief Executive Officer of Tandem Diabetes Care, Inc., a medical device company specializing in the design, development and commercialization of products for people with insulin-dependent diabetes. He has been a member of Tandems Board of Directors since June 2019 and a member of the executive management team since 2013.
"John has an accomplished... More
Acutus Medical Announces Earnings Call Time Change; Fourth Quarter 2020 Earnings Call to Occur at 8 a.m. (Eastern Time)
March 17, 2021 10:58 PM EDTCARLSBAD, Calif., March 17, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (Acutus) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced that it has changed the timing of its previously announced earnings conference call. The time change is entirely the result of an error by the Companys filing agent, Donnelley Financial Solutions, whereby Donnelley Financial Solutions inadvertently filed Acutus financial results for automated distribution at 3 a.m. Pacific Time / 6 a.m. Eastern Time on Thursday, March 18. As a result, Acutus will now host a... More